Estados financieros detallados de Predictive Oncology Inc. (POAI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Predictive Oncology Inc. registró ingresos de $125284 en el último ejercicio fiscal, con un CAGR de 5 años del -36.9%.
Márgenes de los últimos 12 meses: margen bruto 7.1%, margen operativo -14.8%, margen neto -72.4%.
Al precio actual de $4.91, POAI presenta beneficios negativos (P/E no significativo) y un ROE del -488.50%. La capitalización bursátil es de $4M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $456495 | $654836 | $1.4M | $1.4M | $1.3M | $1.4M | $1.5M | $1.6M | $1.6M | $125284 |
| Coste de Ventas | $181620 | $148045 | $415764 | $531810 | $447192 | $487024 | $505107 | $609212 | $826137 | $72622 |
| Beneficio Bruto | $274875 | $506791 | $995891 | $879755 | $805080 | $933656 | $1.0M | $1.0M | $797680 | $52662 |
| I+D | $406000 | $289000 | $1.9M | $3.0M | $372710 | $315850 | $320320 | $122307 | $25987 | $2.1M |
| Generales y Administrativos | $5.6M | $8.3M | $7.0M | $11.7M | $10.9M | $11.7M | $12.5M | $9.1M | $8.9M | $26.3M |
| Gastos Operativos | $6.8M | $8.3M | $8.9M | $23.5M | $26.2M | $21.4M | $27.0M | $13.1M | $11.7M | $28.5M |
| Beneficio Operativo | -$6.5M | -$7.7M | -$7.9M | -$22.6M | -$25.4M | -$20.4M | -$26.0M | -$12.1M | -$10.9M | -$28.4M |
| EBITDA | -$6.4M | -$6.0M | -$7.7M | -$13.1M | -$11.5M | -$12.1M | -$14.0M | -$11.8M | -$10.2M | -$232.2M |
| Gastos por Intereses | $3 | 0 | 0 | 0 | 0 | 0 | $10.7M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$6.5M | -$7.7M | -$10.1M | -$19.4M | -$25.9M | -$20.3M | -$25.7M | -$12.0M | -$10.9M | -$232.9M |
| Impuestos | 0 | $50503 | 0 | 0 | 0 | -$661658 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$6.5M | -$7.7M | -$10.1M | -$19.4M | -$25.9M | -$19.7M | -$25.7M | -$14.0M | -$12.2M | -$233.1M |
| BPA | $-462.28 | $-188.69 | $-157.40 | $-137.14 | $-44.25 | $-7.16 | $-6.98 | $-3.48 | $-2.24 | $-13.37 |
| BPA Diluido | $-462.28 | $-188.69 | $-157.40 | $-137.20 | $-44.25 | $-7.20 | $-6.98 | $-3.48 | $-2.24 | $-13.37 |
| Acciones en Circulación (Diluidas) | $14115 | $31815 | $64080 | $143505 | $597510 | $2.7M | $3.7M | $4.0M | $5.5M | $17.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $3618 | $8674 | $35311 | $3.2M |
| Beneficio Bruto | -$4738 | $7747 | $28541 | $201653 |
| Beneficio Operativo | -$3.3M | -$20.2M | -$7.7M | -$17.2M |
| EBITDA | -$77.6M | -$150.8M | -$7.6M | -$17.2M |
| Beneficio Neto | -$77.7M | -$150.9M | -$7.7M | 0 |
| BPA | $-107.25 | $-36.97 | $-0.36 | $-0.87 |
| BPA Diluido | $-107.25 | $-36.97 | $-0.36 | $-0.87 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.8M | $766189 | $162152 | $150831 | $678332 | $28.2M | $22.1M | $8.7M | $734673 | $10.8M |
| Inversiones a Corto | $284329 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $38919 | $805011 | $729878 | $297055 | $256878 | $354196 | $331196 | $277641 | $745566 | $7.3M |
| Inventario | $272208 | $265045 | $241066 | $190156 | $289535 | $387684 | $430493 | $480803 | $385728 | $24.4M |
| Activos Corrientes | $2.6M | $2.4M | $1.5M | $798264 | $1.5M | $29.5M | $23.4M | $10.1M | $2.2M | $42.8M |
| Inmovilizado Material | $101496 | $87716 | $180453 | $2.2M | $5.2M | $3.3M | $2.0M | $4.0M | $2.4M | $1.7M |
| Fondo de Comercio | 0 | 0 | 0 | $15.7M | $2.8M | $6.9M | 0 | 0 | 0 | 0 |
| Activos Intangibles | $97867 | $95356 | $964495 | $3.6M | $3.4M | $4.0M | $253865 | $252457 | $210113 | 0 |
| Activos Totales | $2.8M | $3.6M | $3.7M | $22.4M | $13.1M | $43.8M | $25.7M | $14.4M | $5.0M | $52.9M |
| Cuentas por Pagar | $220112 | $140462 | $445689 | $3.2M | $1.4M | $1.0M | $943452 | $1.3M | $1.1M | $1.8M |
| Deuda a Corto | 0 | 0 | $1.6M | $5.3M | $4.4M | 0 | 0 | $150408 | 0 | $107951 |
| Pasivos Corrientes | $1.6M | $932340 | $3.7M | $10.9M | $9.3M | $3.2M | $3.9M | $4.0M | $3.6M | $4.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.9M | $932340 | $3.7M | $11.1M | $10.4M | $3.5M | $4.0M | $6.1M | $5.2M | $5.2M |
| Reservas | -$47.0M | -$54.8M | -$63.1M | -$82.5M | -$108.4M | -$128.0M | -$153.8M | -$167.8M | -$180.4M | -$413.5M |
| Patrimonio Neto | $923682 | $2.7M | $53472 | $11.2M | $2.6M | $40.3M | $21.8M | $8.3M | -$202610 | $47.7M |
| Deuda Total | 0 | 0 | $1.6M | $6.0M | $5.9M | $879326 | $180319 | $2.7M | $2.1M | $1.7M |
| Deuda Neta | -$2.0M | -$766189 | $1.5M | $5.8M | $5.2M | -$27.3M | -$21.9M | -$6.0M | $1.4M | -$9.1M |
| Capital Circulante | $1.0M | $1.4M | -$2.2M | -$10.1M | -$7.8M | $26.2M | $19.5M | $6.1M | -$1.4M | $38.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $181667 | $10.8M | $6.9M | $21.9M |
| Activos Totales | $3.1M | $52.9M | $45.2M | $100.4M |
| Pasivos Totales | $80.6M | $5.2M | $5.0M | $66.3M |
| Patrimonio Neto | -$77.4M | $47.7M | $40.3M | $34.0M |
| Deuda Total | $1.9M | $1.7M | $1.4M | $1.2M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$6.5M | -$7.7M | -$10.1M | -$19.4M | -$25.9M | -$19.7M | -$25.7M | -$12.0M | -$10.9M | -$233.1M |
| Amortizaciones | $82356 | $71562 | $147628 | $704883 | $1.0M | $1.3M | $1.3M | $724808 | $695663 | $688576 |
| Compensación en Acciones | $886601 | $4.0M | $1.5M | 0 | $1.2M | $921131 | $522437 | 0 | 0 | 0 |
| Cambio en Capital Circulante | $445995 | -$1.2M | $884299 | $1.9M | -$1.2M | -$1.2M | $866686 | -$780360 | -$914562 | $1.2M |
| Flujo de Caja Operativo | -$4.4M | -$4.5M | -$5.3M | -$8.7M | -$12.3M | -$12.2M | -$12.4M | -$13.2M | -$12.0M | -$10.0M |
| Inversiones (CapEx) | -$44747 | -$55272 | -$232003 | -$26607 | -$360777 | -$962322 | -$475697 | -$21529 | -$9509 | -$3 |
| Adquisiciones | -$11987 | 0 | 0 | $248102 | $193321 | -$9.6M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | -$11526 | -$27654 | -$1509 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.4M | -$4.5M | -$5.5M | -$8.8M | -$12.6M | -$13.2M | -$12.8M | -$13.2M | -$12.0M | -$10.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.7M | -$3.7M | -$3.7M | $21.1M |
| Inversiones (CapEx) | $3 | 0 | -$21000 | -$17.1M |
| Flujo de Caja Libre | -$1.7M | -$3.7M | -$3.8M | $4.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | 0 | $111358 | $571584 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +43.4% | +115.6% | -0.0% | -11.3% | +13.4% | +6.0% | +8.1% | -0.2% | -92.3% |
| Crecimiento Beneficio Neto (anual) | | -18.7% | -30.2% | -92.2% | -33.5% | +24.1% | -30.9% | +45.7% | +12.7% | -1810.4% |
| Crecimiento BPA (anual) | | +59.2% | +16.6% | +12.9% | +67.7% | +83.8% | +2.5% | +50.1% | +35.6% | -496.9% |
| Cambio en Acciones (anual) | | +125.4% | +101.4% | +123.9% | +316.4% | +359.2% | +34.3% | +8.9% | +35.8% | +219.6% |
| Crecimiento FCF (anual) | | -2.0% | -22.3% | -58.7% | -44.1% | -4.4% | +2.5% | -2.8% | +9.4% | +16.8% |
| Margen Bruto | 60.2% | 77.4% | 70.5% | 62.3% | 64.3% | 65.7% | 66.4% | 62.6% | 49.1% | 42.0% |
| Margen Operativo | -1429.6% | -1183.0% | -556.9% | -1604.2% | -2025.1% | -1437.9% | -1729.3% | -744.5% | -673.7% | -22688.6% |
| Margen EBITDA | -1411.5% | -913.5% | -546.4% | -925.9% | -915.0% | -853.9% | -926.9% | -723.3% | -626.0% | -185311.0% |
| Margen Neto | -1429.6% | -1183.0% | -714.5% | -1373.7% | -2067.0% | -1383.6% | -1709.6% | -859.1% | -751.4% | -186053.4% |
| Margen FCF | -969.6% | -689.5% | -391.0% | -620.5% | -1007.6% | -927.1% | -853.3% | -811.6% | -736.9% | -7948.8% |
| Tasa Impositiva Efectiva | -0.0% | -0.7% | -0.0% | -0.0% | -0.0% | 3.3% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-313.58 | $-141.91 | $-86.14 | $-61.04 | $-21.12 | $-4.80 | $-3.49 | $-3.29 | $-2.19 | $-0.57 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $14115 | $31815 | $64080 | $141330 | $584985 | $2.7M | $3.7M | $4.0M | $5.5M | $17.4M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -488.50% |
| Rentabilidad sobre capital invertido | -57.56% |
| Rentabilidad sobre activos | -440.73% |
| Margen bruto | 7.15% |
| Margen operativo | -1483.87% |
| Margen neto | -7242.42% |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 1.45 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 2.62 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -18.17 | -16.06 | -11.80 | -5.71 | -4.96 | -39.89 | -13.19 | -14.18 | -5.49 | -0.45 |
| P/VC | 128.36 | 35.81 | 2225.40 | 9.85 | 48.61 | 19.36 | 15.60 | 23.95 | -331.08 | 2.17 |
| P/V | 259.73 | 147.21 | 84.30 | 78.40 | 102.58 | 548.85 | 225.50 | 121.73 | 41.31 | 827.78 |
| Margen Bruto | 60.2% | 77.4% | 70.5% | 62.3% | 64.3% | 65.7% | 66.4% | 62.6% | 49.1% | 42.0% |
| Margen Operativo | -1429.6% | -1183.0% | -556.9% | -1604.2% | -2025.1% | -1437.9% | -1729.3% | -744.5% | -673.7% | -22688.6% |
| Margen Neto | -1429.6% | -1183.0% | -714.5% | -1373.7% | -2067.0% | -1383.6% | -1709.6% | -859.1% | -751.4% | -186053.4% |